Company intelligence / Profile preview

Foundation 14

Ownership: Private
Development stage: Other

Overview

Foundation 14 is a stealth-stage biotechnology company focused on developing novel therapeutic approaches in oncology. The company is reportedly leveraging a proprietary platform to target specific biological pathways involved in cancer progression. While detailed information regarding its specific drug candidates and molecular targets remains undisclosed, Foundation 14 is part of a wave of early-stage ventures seeking to address unmet needs in precision medicine. The company is currently in the pre-clinical phase of development, focusing on validating its core technology and identifying lead assets for future clinical evaluation.

Therapeutic areas: Oncology
Modalities: Small molecule
Industry: Biotech

Beyond the preview

Go deeper on Foundation 14.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Foundation 14.

Explore the full profile